NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that Michael Margolis, R.Ph., has been appointed as its Head of Healthcare Investment Banking. Mr. Margolis has been a Managing Director at the firm since 2010.
“Michael has been instrumental in building our healthcare franchise, and we are excited to have his leadership as we continue to grow that effort,” said Byron Roth, Chairman and CEO of ROTH.
Margolis commented, “I look forward to continuing to work with our healthcare team to provide the investment banking services that are required for the innovative work by many of the domestic and international biotech, medical device, and specialty pharmaceutical companies.”
ROTH’s Healthcare banking team has raised over $12.4 billion in 359 Healthcare transactions since 2010. (Source: ROTH Capital Partners | 01/05/2017)
About ROTH Capital Partners, LLC:
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, Calif., ROTH is privately-held and owned by its employees, and maintains offices throughout the U.S. For more information on ROTH, please visit www.roth.com.